United States. General Accounting Office. (1996). FDA laboratories: Magnitude of benefits associated with consolidation is questionable : report to congressional requesters. The Office.
Chicago Style (17th ed.) CitationUnited States. General Accounting Office. FDA Laboratories: Magnitude of Benefits Associated with Consolidation Is Questionable : Report to Congressional Requesters. Washington, D.C.: The Office, 1996.
MLA (9th ed.) CitationUnited States. General Accounting Office. FDA Laboratories: Magnitude of Benefits Associated with Consolidation Is Questionable : Report to Congressional Requesters. The Office, 1996.
Warning: These citations may not always be 100% accurate.